A neurological basis of stuttering? [4]

Lancet Neurology

Volumn 1, Issue 7, 2002, Pages 407-

  Maguire, Gerald A ^a   Riley, Glyndon D ^a   Yu, Benjamin P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; DOPAMINE;

BEHAVIOR; BRAIN CORTEX; BRAIN DISEASE; BRAIN REGION; DRUG TOLERABILITY; HUMAN; LARYNX DISORDER; LEFT HEMISPHERE; LETTER; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RIGHT HEMISPHERE; SPEECH ARTICULATION; STRUCTURE ANALYSIS; STUTTERING; TONGUE DISEASE; ADAPTATION; CORPUS STRIATUM; HEMISPHERIC DOMINANCE; METABOLISM; NERVE TRACT; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; FUNCTIONAL LATERALITY; HUMANS; NEURAL PATHWAYS; STUTTERING;

EID: 0041851010     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00217-X     Document Type: Letter

References (9)

1. Sommer M., Koch M.A., Paulus W., Weiller C., Buchel C. Disconnection of speech-relevant brain areas in persistent developmental stuttering. Lancet. 360:2002;380-383.
2. Wu J.C., Maguire G.A., Riley G., et al. A positron emission tomography [18F] deoxyglucose study of developmental stuttering. Neuroreport. 6:1995;501-505.
3. Pool K.D., Devous M.D., Freeman F.J., Watson B.C., Finitzo T. Regional cerebral blood flow in developmental stutterers. Arch Neurol. 48:1991;509-512.
4. Wu J.C., Riley G., Maguire G., Najafi A., Tang C. PET scan evidence of parallel cerebral systems related to treatment effects: FDG and FDOPA PET scan findings. Hulstijn W., Peters H.F.M., Van Lieshout P.H.H.M. Speech production: motor control, brain research and fluency disorders. 1997;329-339 Elsevier Science, Amsterdam.
5. Maguire G.A., Riley G.D., Franklin D.L., et al. The dopamine hypothesis of stuttering and its treatment implications. Int J Neuropsychopharmacol. 3:(suppl 1):2000;S12.
6. Wu J.C., Maguire G., Riley G., et al. Increased dopamine activity associated with stuttering. Neuroreport. 8:1997;767-770.
7. Wood F., Stump D. Patterns of regional cerebral blood flow during attempted reading aloud by stutterers both on and off haloperidol medication: evidence for inadequate left frontal activation during stuttering. Brain Lang. 9:1980;141-144.
8. Buchsbaum M.S., Potkin S.G., Siegel B.V. Jr, et al. Striatal metabolic rate in clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry. 49:1992;966-974.
9. Maguire G.A., Riley G.D., Franklin D.L., Gottshalk L.A. Risperidone for the treatment of stuttering. J Clin Psychopharmacol. 20:2000;479-482.